Journal: iScience
Article Title: Akkermansia muciniphila ameliorates fatty liver through microbiota-derived α-ketoisovaleric acid metabolism and hepatic PI3K/Akt signaling
doi: 10.1016/j.isci.2025.112458
Figure Lengend Snippet: α-ketoisovaleric acid is the key metabolite in improving hepatic lipid metabolism via PI3K/Akt pathway in obese mice (A) Flowchart of α-ketoisovaleric acid compensation experiment. All mice, except for the Con group, were fed an HFHCD from week 1 to week 8. α-ketoisovaleric acid group was orally administered α-ketoisovaleric acid every day, while the Con and Mod groups were given saline. (B) Representative photographs of mouse livers from each group. (C–H) Western blot in the PI3K/Akt pathway in mouse liver: p-PI3K/PI3K, p -AMPK/AMPK, p -Akt/Akt, PPARγ/GAPDH, and SREBP-1c/GAPDH. (I) mRNA levels of genes related to lipogenesis (ACC1, FASN, and PPARγ), lipid oxidation (CPT1α), and lipid uptake (SREBP-1c) in mouse liver. (J) Akk improves hepatic lipid metabolism via PI3K/Akt pathway through α-ketoisovaleric acid. Data are expressed as mean ± SD (n = 6–8), ∗ p < 0.05, ∗∗ p < 0.01, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA. Scale bars: 1 cm.
Article Snippet: Rabbit anti-p-PI3K (Tyr458) antibody , Cell Signaling Technology , Cat# 4228, RRID: AB_659940.
Techniques: Saline, Western Blot